Kaloyannidis P, Al Zayer M, Al Darweesh M, Al Batran M, et al. Brentuximab vedotin plus bendamustine versus platinum-based regimens as 1st salvage therapy and 'bridge' to autologous hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma. Leuk Lymphoma 2023 Jan 11:1-4. doi: 10.1080/10428194.2022.2164195.
PMID: 36628991